ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
158 hedge funds and large institutions have $950M invested in Achillion Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 62 increasing their positions, 43 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
9% less funds holding
Funds holding: 173 → 158 (-15)
37% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 41
Holders
158
Holding in Top 10
3
Calls
$37.5M
Puts
$18.6M
Top Buyers
| 1 | +$74.3M | |
| 2 | +$16.4M | |
| 3 | +$16M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$15.4M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$11.6M |
Top Sellers
| 1 | -$27.7M | |
| 2 | -$27.4M | |
| 3 | -$22.9M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$22.6M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$15.2M |